V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008999 | 310007500 | 1.78 | 61 | Palliative (P) | 2014-05-17 | 2015-10-05 | Trial Unspecified | Y | N | 310007284 | TRIAL |
| 310009000 | 310003705 | 1.8 | 65 | Neo-adjuvant (N) | 2018-08-06 | 2018-08-15 | CHOP - 14 days | N | N | 310007302 | CHOP |
| 310009001 | 310003708 | null | 74.7 | Palliative (P) | 2016-09-08 | 2016-09-26 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310007307 | LIPOSOMAL DOXORUBICIN |
| 310009002 | 310003709 | 1.68 | 55.7 | Palliative (P) | 2016-11-15 | 2016-11-15 | Trial Unspecified | 1 | N | 310007311 | TRIAL |
| 310009003 | 310003710 | 1.61 | 45.5 | null | 2015-06-07 | 2015-06-16 | Liposomal Doxorubicin (Caelyx) | 02 | null | 310007315 | LIPOSOMAL DOXORUBICIN |
| 310009004 | 310003715 | 1.46 | 89 | Palliative (P) | 2016-08-29 | 2017-09-23 | Liposomal Doxorubicin (20mg/m2) | N | N | 310007322 | LIPOSOMAL DOXORUBICIN |
| 310009005 | 310003715 | 1.63 | 113.8 | Palliative (P) | 2016-08-02 | 2016-10-21 | Bevacizumab | N | N | 310007322 | BEVACIZUMAB |
| 310009006 | 310011501 | 1.73 | 89 | Palliative (P) | 2014-12-31 | 2015-05-29 | Bevacizumab 7.5mg/kg | N | N | 310007332 | BEVACIZUMAB |
| 310009007 | 310011884 | 1.73 | 88.8 | Palliative (P) | 2014-01-01 | 2014-06-27 | Bevacizumab 7.5mg/kg | 2 | N | 310007339 | BEVACIZUMAB |
| 310009008 | 310003716 | 1.65 | 90.2 | Disease modification (D) | 2013-11-21 | 2013-12-19 | Trial Unspecified | N | N | 310007355 | TRIAL |
| 310009009 | 310007507 | 1.8 | 69.1 | Adjuvant (A) | 2016-12-29 | 2016-12-31 | Trial Unspecified | N | N | 310007357 | TRIAL |
| 310009010 | 310003719 | 1.84 | 81.4 | Adjuvant (A) | 2014-04-19 | 2014-10-03 | Bevacizumab 15mg/kg | 02 | null | 310007362 | BEVACIZUMAB |
| 310009011 | 310007509 | 1.59 | 69.6 | Palliative (P) | 2017-12-13 | 2017-12-15 | Trial Unspecified | 01 | N | 310007362 | TRIAL |
| 310009012 | 310003721 | 1.63 | 86.4 | Disease modification (D) | 2015-02-17 | 2015-02-18 | GemCarbo Days 1+8 | N | N | 310007366 | GEMCARBO |
| 310009013 | 310003724 | 0 | 51 | null | 2017-06-03 | 2017-06-06 | Trial Unspecified | Y | N | 310007370 | TRIAL |
| 310009014 | 310003727 | 1.53 | 65.9 | Palliative (P) | 2016-12-25 | 2016-12-25 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 310007371 | LIPOSOMAL DOXORUBICIN |
| 310009015 | 310003727 | null | 77.8 | Palliative (P) | 2018-05-18 | 2018-05-21 | CHOP | N | N | 310007371 | CHOP |
| 310009016 | 310003729 | 1.65 | 51 | Palliative (P) | 2015-05-02 | 2015-10-28 | Liposomal Doxorubicin (Caelyx) | 02 | N | 310007387 | LIPOSOMAL DOXORUBICIN |
| 310009017 | 310003730 | 1.69 | null | Palliative (P) | 2016-06-16 | 2016-07-24 | CHOP - 21 days | 02 | null | 310007389 | CHOP |
| 310009018 | 310003732 | 1.53 | 93 | Curative (C) | 2017-05-21 | 2017-09-14 | CHOP - 21 days | 2 | N | 310007391 | CHOP |
| 310009019 | 310010567 | 1.75 | 84.5 | Palliative (P) | 2013-09-12 | 2013-09-22 | Liposomal Doxorubicin (20mg/m2) | N | N | 310007408 | LIPOSOMAL DOXORUBICIN |
| 310009020 | 310003734 | 1.47 | 90 | Palliative (P) | 2015-06-29 | 2015-06-30 | Liposomal Doxorubicin 40mg/m2 | 2 | null | 310007411 | LIPOSOMAL DOXORUBICIN |
| 310009021 | 310003737 | null | 78.3 | Palliative (P) | 2018-08-23 | 2018-09-08 | Liposomal Doxorubicin (Caelyx) | N | N | 310007415 | LIPOSOMAL DOXORUBICIN |
| 310009022 | 310003737 | 1.96 | 78.6 | Palliative (P) | 2016-08-16 | 2016-08-21 | Trial Unspecified | 01 | N | 310007415 | TRIAL |
| 310009023 | 310010568 | 1.74 | 65 | Palliative (P) | 2015-04-03 | 2015-06-04 | Trial Unspecified | N | N | 310007425 | TRIAL |
| 310009024 | 310003742 | 1.74 | 78 | Palliative (P) | 2013-03-25 | 2013-04-20 | CHOP - 14 days | 02 | N | 310007443 | CHOP |
| 310009025 | 310010569 | 1.82 | 78.3 | Palliative (P) | 2016-03-02 | 2016-03-02 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310007451 | LIPOSOMAL DOXORUBICIN |
| 310009026 | 310003743 | 1.72 | 63 | null | 2014-07-14 | 2014-07-14 | Trial Unspecified | 1 | N | 310007451 | TRIAL |
| 310009028 | 310007525 | 1.58 | 61.8 | Palliative (P) | 2016-11-26 | 2016-12-07 | CHEMO-T TRIAL | 1 | N | 310007457 | TRIAL |
| 310009030 | 310003749 | 1.61 | 74.1 | Adjuvant (A) | 2014-07-28 | 2014-10-08 | Bevacizumab 7.5mg/kg | N | N | 310007466 | BEVACIZUMAB |
| 310009031 | 310003750 | null | 72.2 | Adjuvant (A) | 2014-06-26 | 2014-06-27 | Trial Unspecified | N | N | 310007467 | TRIAL |
| 310009032 | 310003752 | 1.5 | 52.2 | Palliative (P) | 2016-12-25 | 2017-01-01 | GEMCARBO | N | N | 310007468 | GEMCARBO |
| 310009033 | 310003755 | 1.74 | 71.4 | Adjuvant (A) | 2015-08-05 | 2015-09-03 | CHOP - 21 days | 02 | N | 310007478 | CHOP |
| 310009034 | 310009515 | 1.86 | 65 | Unknown (U) | 2013-11-16 | 2013-11-19 | GEMCARBO | 02 | N | 310007481 | GEMCARBO |
| 310009035 | 310003758 | 1.64 | 113.8 | Curative (C) | 2015-12-25 | 2015-12-25 | CHOP | N | N | 310007481 | CHOP |
| 310009039 | 310003766 | 1.81 | 100 | Palliative (P) | 2016-06-04 | 2016-06-21 | Bevacizumab | N | N | 310007512 | BEVACIZUMAB |
| 310009040 | 310003768 | 1.74 | 53.3 | Palliative (P) | 2013-12-25 | 2014-01-05 | Bevacizumab 7.5mg/kg | 02 | N | 310007518 | BEVACIZUMAB |
| 310009041 | 310003771 | 1.6 | null | Palliative (P) | 2013-10-30 | 2014-01-24 | CHOP | N | N | 310007520 | CHOP |
| 310009042 | 310003773 | 1.54 | 140 | Palliative (P) | 2014-01-13 | 2014-01-29 | Liposomal Doxorubicin (Caelyx) | N | Y | 310007527 | LIPOSOMAL DOXORUBICIN |
| 310009043 | 310003775 | null | 0 | Palliative (P) | 2017-06-27 | 2017-07-27 | Trial Unspecified | 01 | N | 310007534 | TRIAL |
| 310009044 | 310003776 | 1.83 | 70.3 | null | null | 2014-10-11 | CARBOPLATIN + GEMCITABINE | 2 | N | 310007538 | GEMCARBO |
| 310009045 | 310003778 | 1.76 | 54.2 | null | 2014-05-11 | 2014-05-15 | Liposomal Doxorubicin 50mg/m2 | 02 | null | 310007540 | LIPOSOMAL DOXORUBICIN |
| 310009046 | 310003779 | 1.64 | 95 | Curative (C) | 2017-05-09 | 2017-05-19 | CHOP - 21 days | 02 | N | 310007543 | CHOP |
| 310009047 | 310003780 | 1.66 | 74.9 | Palliative (P) | 2015-07-23 | 2017-09-22 | CHEMO-T TRIAL | 01 | N | 310007548 | TRIAL |
| 310009048 | 310003783 | 1.73 | null | Palliative (P) | 2013-05-03 | 2013-06-19 | CHOP - 14 days | N | N | 310007554 | CHOP |
| 310009049 | 310003787 | 1.79 | 100 | Not known (9) | 2015-08-12 | 2015-08-12 | Bevacizumab 7.5mg/kg | N | N | 310007565 | BEVACIZUMAB |
| 310009050 | 310003789 | null | 128 | null | 2014-08-14 | 2014-09-08 | CARBOPLATIN + GEMCITABINE | 2 | N | 310007569 | GEMCARBO |
| 310009051 | 310003792 | 1.58 | 59 | Palliative (P) | 2017-10-05 | 2017-10-12 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310007577 | LIPOSOMAL DOXORUBICIN |
| 310009052 | 310003793 | 1.59 | 65 | null | 2017-11-01 | 2018-03-14 | CHOP | 02 | N | 310007578 | CHOP |
| 310009053 | 310003796 | null | 107.5 | Palliative (P) | 2016-01-03 | 2016-01-30 | Trial Unspecified | 1 | N | 310007583 | TRIAL |